Journal Information
Vol. 43. Issue 2.
Pages 129 (February 2007)
Share
Share
Download PDF
More article options
Vol. 43. Issue 2.
Pages 129 (February 2007)
Letters to the Editor
Full text access
Development of Extrapulmonary Tuberculosis
Visits
3485
Iván Landiresa, Virginia Núñez-Samudiob, Erick Landiresb
a Gorgas Memorial Institute of Health Studies, Panamá, Panama
b Centro Integral de Radiodiagnóstico, Chitré, Panama
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
ZM Fuentes, JA Caminero.
Controversias en el tratamiento de la tuberculosis extrapulmo-nar.
Arch Bronconeumol, 42 (2006), pp. 194-201
[2]
PJ Cardona.
Mycobacterium tuberculosis y Homo sapiens, un largo camino reconido y por recorrer.
Med Clin (Bare), 126 (2006), pp. 771-773
[3]
BR Bloom, PM Small.
The evolving relation between humans and Mycobacterium tuberculosis..
N Engl J Med, 338 (1998), pp. 677-678
[4]
L Tsenova, B Mangaliso, G Muller, et al.
Use of IM1D3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.
Antimicrob Agents Chemother, 46 (2002), pp. 1887-1895
[5]
P Selvaraj, U Sriram, S Mathan Kurian.
Tumour necrosis factor alpha (−238 and −308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLAA, B, and DR genes.
Tuberculosis (Edinb), 81 (2001), pp. 335-341
[6]
A Baena, JY Ieung, AD Sullivan, et al.
TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry.
Genes Immun, 3 (2002), pp. 482-487
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?